Commercial leader with proven track record of driving growth, surgeon adoption, and market expansion with innovative spine and surgical ...
ROSELAND, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Milestone Scientific Inc. (MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today ...
Milestone Scientific launched the CompuFlo® Epidural System at Advanced Spine and Pain Management, enhancing safety and efficiency in epidural procedures. Milestone Scientific Inc., a developer of ...
North American Spine and Pain has announced the introduction of a new clinical approach to back pain management, expanding its suite of interventional treatments designed to address chronic and acute ...
BROOMFIELD, Colo., April 29, 2025 (GLOBE NEWSWIRE) -- Aclarion, Inc. (ACON), (“Aclarion” or the “Company”) (Nasdaq: ACON, ACONW), a healthcare technology ...
Pittsburgh-based Highmark has signed on as AppliedVR's first commercial payer partner, making its flagship VR device for chronic lower back pain a covered treatment for more than 4 million plan ...
FDA has previously agreed on the design of this 300-patient randomized, placebo-controlled confirmatory Phase 3 trial, and the 12-month primary endpoint of pain reduction as an approvable indication.
We practice a different kind of pain medicine beyond injections with treatments like DiscSeel®, intradiscal PRP, and Magnetic Peripheral Nerve Stimulation most patients didn’t know were available.” — ...
The value-based care and direct-to-employer payment models are gaining traction in both the orthopedic and spine spaces, but there are still some significant hurdles to industrywide adoption.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results